Teva to keep propofol out of death-row prisons; GW, Almirall may yank Sativex in Germany on lowball price; GlaxoSmithKline, Intermune win NICE nods for Revolade, Esbriet;

@FiercePharma: Novartis CEO Joe Jimenez's latest interview with a big media outlet. How $NVS forges ahead, from CNN. Report | Follow @FiercePharma

@EricPFierce: Canada's Apotex, already in NAFTA fight with US over 2009 FDA import ban, finds itself back in the FDA doghouse. Article | Follow @EricPFierce

> Teva Pharmaceutical Industries ($TEVA) says it will resume manufacturing the anesthetic propofol and will control distribution to prevent its use by prisons in executions. Report

> GW Pharmaceuticals and its partner Almirall may stop selling their Sativex drug for multiple sclerosis patients in Germany after officials there set a price "significantly lower" than that in other European countries. Report

> GlaxoSmithKline's ($GSK) Revolade won a thumbs-up from the National Institute for Health and Clinical Excellence, as a treatment for chronic immune thrombocytopenic purpura. Report

> Teva Pharmaceutical Industries chose former Dyax executive Ivana Magovcevic-Liebisch to be its SVP and head of business development, a newly created post. Release | Release

> InterMune's ($ITMN) lung drug Esbriet won a recommendation from NICE as a treatment for idiopathic pulmonary fibrosis. Report

> Germany's generics maker Stada posted a 7% increase in 2012 sales of €1.84 billion ($2.4 billion); profits grew fourfold on cost-cutting and some one-time gains. Release

Medical Device News

 @FierceMedDev: More worry for Intuitive as MA questions robotic surgery. Item | Follow @FierceMedDev

 @MarkHFierce: Our latest special report: Med Tech's 2012 R&D big spenders. Who made the list? Feature | Follow @MarkHFierce

 @DamianFierce: A House Dem has taken up the medical device tax repeal cause, introducing a bill to kill the charge. Report | Follow @DamianFierce

> St. Jude claims "landmark study" quells concerns over heart-plug benefits. Article

> Abbott's MitraClip draws mixed vote from FDA panel. News

> Swiss develop multitasking, implantable Dx chip. More

Biotech News

 @FierceBiotech: From New database a boon for genomics research. Story | Follow @FierceBiotech

@JohnCFierce: Moderna will now triple its staff in Cambridge, MA, if you're looking for a job. Article | Follow @JohnCFierce

@RyanMFierce: Celgene makes big splash in gene therapy with two cancer collaborations. News | Follow @RyanMFierce

> Teva touts fresh PhIII evidence of oral MS drug's potential. News

> Enanta prices IPO shares at low end of range. Item

> GlaxoSmithKline reports another batch of weak results for malaria jab. Story

> Gene therapy combats acute leukemia in small study. More

Pharma Manufacturing News

> Teva returns to market with propofol. Story

> India has plan to meet Europe's new API regs. Report

> Sanofi again having manufacturing issues involving TB drug. Article

> FDA again on Apotex's case for plant problems. More

Vaccines News

> Flexible flu threatens pandemic preparedness. Report

> Anthrax vax vexes bioethics committee. Story

> U.K. smallpox rethink prompts stockpiling criticisms. Article

> Struggle against HPV vaccine skepticism intensifying. More

And Finally... Norovirus in U.S. children causes more than 1 million doctor visits each year at a cost of some $273 million. Report